Of the 43 breast cancer patients, 14 patients exhibited NPY1R expression and 16 patients expressed FAM83A, however, these two marker genes were undetectable in the peripheral blood of the 20 healthy control subjects. Here, NPY1R is linked to breast carcinoma.